Therapeutic targets in chronic myeloid l
✍
Nicholas B. Heaney; Tessa L. Holyoake
📂
Article
📅
2007
🏛
John Wiley and Sons
🌐
English
⚖ 162 KB
## Abstract Chronic myeloid leukaemia (CML) is a clonal disorder of the haemopoietic stem cell arising as a consequence of the formation of the __bcr‐abl__ oncogene. The particular molecular basis of this condition has enabled the development of therapies that selectively target diseased cells. The